1. Virtual Investor Forum set for December 11th, inviting diverse participation. 2. No cost to attend live presentations and schedule one-on-one meetings. 3. Focus on life sciences innovation, providing insights for investors.
FAQ
Why Bullish?
The Life Sciences Virtual Investor Forum could showcase BICX's developments to potential investors, similar to prior events that boosted interest and valuation for biotech stocks. Companies participating often see positive sentiment and increased trading volume post-event.
How important is it?
The event may enhance BICX's visibility in the life sciences sector, influencing investor sentiment and potential demand, which can positively impact stock valuation.
Why Short Term?
Expect immediate interest and potential short-term price movement due to the forum's visibility, akin to past forums where significant stock responses occurred shortly after similar presentations.
NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Life Sciences Virtual Investor Forum to be held December 11th.
Individual investors, institutional investors, advisors, and analysts are invited to attend.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.
Please Schedule 1x1 Meetings Here
"We are excited to host our Life Sciences Virtual Investor Forum on December 11th," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "The life sciences sector is innovating at a remarkable pace, and our event gives investors a front-row seat to that momentum."
December 11th
| Eastern Time (ET) | Presentation | Ticker(s) |
| 10:00 AM | Prostatype Genomics AB | (OTCQB:PGABF, Nasdaq First North: PROGEN)) |
| 11:00 AM | Defence Therapeutics Inc. | (OTCQB:DTCFF, CSE:DTC) |
| 11:30 AM | EcholQ Ltd. | (OTCQB:ECHQF, ASX: EIQ)) |
| 12:00 PM | Thiogenesis Therapeutics Corp. | (OTCQX:TTIPF, TSXV:TTI) |
| 12:30 PM | Genvor Inc. | (OTCQB:GNVR) |
| 2:00 PM | InMed Pharmaceuticals Inc. | (NASDAQ:INM) |
| 2:30 PM | BioCorRx Inc. | (OTCQB:BICX) |
| 3:00 PM | Amplia Therapeutics Ltd. | (OTCQB:INNMF, ASX: ATX)) |
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com
Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
